Weekly Digest – January 2025 Weekly Digest – January 2025 27 Jan 2025: Enhertu approved in the US as first HER2-directed therapy for patients with HER2-low or HER2-ultralow metastatic Breast Cancer following disease progression after one or more endocrine therapies […]
Contact:
info@ciscientists.com
+1-908-212-7484
Optimal Dose
For a subscription, please provide your email id